Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-EN
Language French English
Date Updated 2022-05-24 2022-05-10
Drug Identification Number 02181479 02181479
Brand name INHIBACE PLUS INHIBACE PLUS
Common or Proper name INHIBACE PLUS INHIBACE PLUS
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients HYDROCHLOROTHIAZIDE CILAZAPRIL HYDROCHLOROTHIAZIDE CILAZAPRIL
Strength(s) 12.5MG 5MG 12.5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 28 tablets 28 tablets
ATC code C09BA C09BA
ATC description ACE INHIBITORS, COMBINATIONS ACE INHIBITORS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-09 2022-05-09
Estimated end date 2022-08-31 2022-08-31
Actual end date 2022-05-24
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments